TMCnet News
Myomo Brings MyoPro to Adolescent PatientsMyomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company, today announced that its MyoPro myoelectric arm orthosis (powered brace) is now available to adolescent patients with paralyzed or weakened arms. MyoPro is the only lightweight wearable device on the market that can help restore substantial functionality in the arms and hands of individuals who are suffering from the effects of a neuromuscular disease or injury. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180606005268/en/ Zeke, 18, MyoPro User (Photo: Business Wire) Myomo originally developed MyoPro to assist adults suffering from brachial plexus injury (BPI), brain or spinal cord injury, stroke, multiple sclerosis or ALS. MyoPro is now available to help restore upper limb functionality in adolescents with similar neuromuscular conditions. In order to facilitate MyoPro fittings and delivery to adolescent patients, Myomo has partnered with Easterseals DuPage & Fox Valley (Chicago area), one of the largest and most highly regarded pediatric outpatient rehabilitation centers in the nation, and is exploring partnerships with additional youth institutions and children's hospitals that are committed to providing innovative care to adolescents and children with specialized needs. Paul R. Gudonis, Chairman and CEO of Myomo, said, "For adolescents who suffer from a neuromuscular condition like cerebral palsy or BPI, and whose options for treatment and care have been liited, MyoPro represents new hope. We can now provide these teens with a chance to help restore function in their arms and, as a result, improve their quality of life. This announcement represents an expansion in our market reach and our ability to serve those most in need of our technology." "Our partnership provides Easterseals DuPage & Fox Valley with cutting-edge technology for our therapists and clients," said Kathy Schrock, vice president of clinical services, Easterseals DuPage & Fox Valley, Illinois. "MyoPro will help develop arm control for adolescent clients with neurological disorders, giving them greater independence." Based on patented technology developed at MIT (News - Alert), MyoPro is a powered brace that senses a patient's own EMG signals through non-invasive sensors and restores function to the paralyzed or weakened arm. This allows MyoPro users to perform activities of daily living including feeding themselves, carrying objects and doing household tasks. Many adult patients are even able to return to work. For more information about MyoPro for adolescents, please visit www.myomo.com/adolescents.
About Myomo
Forward Looking Statements
View source version on businesswire.com: https://www.businesswire.com/news/home/20180606005268/en/ |